Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

AAR

- PMLiVE

NHS Long-term Plan welcomed – but warnings on staff and overpromising

New emphasis on prevention, integrated healthcare and digital services

- PMLiVE

Afinitor and Uptravi gain funding from NHS England

Rare disease treatments navigate tricky market access route

- PMLiVE

Pharma’s confidence in Brexit deal falls as vote looms

Most EMIG members have little or no confidence in the government’s abilities to obtain a good deal

- PMLiVE

Post-Brexit immigration policy has a critical missing piece

ABPI welcomes focus on skills, but UK must respond fast to skills gaps

- PMLiVE

Business warning as talk of Brexit ‘No deal’ grows

'Managed no deal' plan is 'not a credible position' warns business

- PMLiVE

Novartis withdraws EU filing for canakinumab

Further setback for cardiovascular blockbuster potential

- PMLiVE

NICE appraisal fees to be introduced despite opposition

Concessions made for small companies

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

- PMLiVE

‘No deal’ Brexit could see pharmacists take lead amid drug shortages

Government steps up preparations as Brexit day nears

- PMLiVE

As May delays, industry warns again of ‘no-deal’ Brexit

Brussels offers warm words, but no renegotiation

- PMLiVE

Industry frustrated by late warning on ‘no deal’ Brexit disruption

Dover and Folkestone could have 6 months of disruption

- PMLiVE

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links